GM-CSF

Modern scientific understanding has considered multiple sclerosis to be a disease controlled by the T cell, a type of white...


The results of the pivotal OPTiM study have shown that Talimogene laherparepvec monotherapy is the first oncolytic immunotherapy to demonstrate...


The maturation, recruitment and survival of eosinophils in the respiratory tract are determined by IL-3, GM-CSF, but especially by IL-5,...


A new breast cancer vaccine candidate, ( GP2 ), provides further evidence of the potential of immunotherapy in preventing disease...


GP2 is a HER2 derived, HLA-A2+-restricted immunogenic peptide designed to stimulate CD8+T cells to recognize tumor cells with any level...


Mavrilimumab and Sifalimumab have met their primary endpoints in respective phase II studies, demonstrating further pipeline progress in core therapeutic...


Dendreon has announced that the European Commission ( EC ) has granted marketing authorization for Provenge ( autologous peripheral blood...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of...


The results from the phase 3 trial in melanoma, which has evaluated the efficacy and safety of Talimogene Laherparepvec for...


Rresults from a pivotal phase 3 trial evaluating Talimogene Laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma...


Provenge ( Sipuleucel-T ) is an autologous cellular immunotherapy designed to stimulate a patient’s own immune system against cancer. Provenge...


Treatment with a recombinant form of a hematopoietic growth factor GM-CSF, Sargramostim ( Leukine ), significantly reduced symptom...


Most treatments for Crohn's, an autoimmune disorder, are geared to suppress the immune response, but a new study demonstrates that...